ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NRIX Nurix Therapeutics Inc

12.35
-0.01 (-0.08%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Nurix Therapeutics Inc NRIX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.08% 12.35 14:00:07
Open Price Low Price High Price Close Price Previous Close
12.49 12.17 12.61 12.35 12.36
more quote information »

Recent News

Date Time Source Heading
17/4/202408:21GLOBENurix Therapeutics Announces Closing of Public Offering and..
12/4/202413:38GLOBENurix Therapeutics Announces Pricing of Upsized $175.0..
12/4/202406:00GLOBENurix Therapeutics Announces Proposed Public Offering
10/4/202421:00GLOBENurix Therapeutics Reports First Quarter Fiscal 2024..
10/4/202403:15GLOBENurix Therapeutics Reports First Clinical Evidence of CNS..
09/4/202421:00GLOBENurix Therapeutics Announces Extension of Strategic..
03/4/202422:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
02/4/202422:00GLOBENurix Therapeutics Announces Extension of Strategic..
25/3/202422:00GLOBENurix Therapeutics is Part of a Team of International..
21/3/202400:40GLOBENurix Presents the Discovery and Chemical Structure of..
11/3/202422:02EDGAR2Form 8-K - Current report
11/3/202422:00GLOBENurix Therapeutics Announces U.S. FDA Lifts Partial Clinical..
07/3/202408:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
06/3/202408:30GLOBENurix Therapeutics Announces Presentations at the American..
17/2/202411:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:22EDGAR2Form 144 - Report of proposed sale of securities
16/2/202408:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/2/202408:01EDGAR2Form 8-K - Current report
16/2/202408:00GLOBENurix Therapeutics Reports Fourth Quarter and Fiscal Year..
15/2/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202408:01GLOBENurix Therapeutics Announces Publication in the Journal..
31/1/202410:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202410:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202410:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202408:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/1/202408:48DJNNurix Therapeutics Gets FDA Fast-Track Designation for..
17/1/202408:01GLOBENurix Therapeutics Receives U.S. FDA Fast Track Designation..
08/1/202423:03EDGAR2Form 8-K - Current report
08/1/202423:00GLOBENurix Therapeutics Outlines 2024 Strategic Priorities with..
03/1/202408:01GLOBENurix Therapeutics to Present at 42nd Annual J.P. Morgan..
22/12/202309:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202308:19EDGAR2Form 144 - Report of proposed sale of securities
14/12/202308:32GLOBEJudith A. Reinsdorf and Katherine M. Sandstrom Named to Toll..
12/12/202304:03EDGAR2Form 8-K - Current report
12/12/202304:00GLOBENurix Therapeutics Presents Positive Clinical Data from Its..
05/12/202308:01GLOBENurix Therapeutics Announces Webcast To Review Data from Its..
13/11/202323:01EDGAR2Form 8-K - Current report
08/11/202308:01GLOBENurix Therapeutics to Participate in Upcoming Investor..
03/11/202300:00GLOBENurix Therapeutics Announces Presentations at the 65th..
02/11/202308:16DJNNurix Therapeutics Says FDA Places Partial Clinical Hold on..
02/11/202307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202307:02EDGAR2Form 8-K - Current report
02/11/202307:01GLOBENurix Therapeutics Announces Partial Clinical Hold For..
13/10/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

Delayed Upgrade Clock